LOL! The sarcasm cracks me up- cuzzola is the president of FRTD
Erie, PA., January 25, 2013 – Fortitude Group Inc., (Pink OTC Market: FRTD) Today introduces Christopher J. Cuzzola as President.
Thomas Parilla CEO of Fortitude Group Inc. is pleased to announce that he has resigned from his position as President, and that Christopher J. Cuzzola has agreed to accept the position of President.
Christopher J. Cuzzola received a M.Ed. in Administrative Leadership, Learning Theory, and Design from Edinboro University and a B.A. from Mercyhurst University. Cuzzola brings a history of exceptional performance applying his entrepreneurial skills to the challenging life science medical device industry.
During his career with Pfizer, Chris was a consistent high achiever while earning several top specialty and hospital sales performance awards, including a number one ranking as national sales representative of the year. Cuzzola has extensive training in various disease states including infectious diseases. In addition to family and professional passions, Chris remains dedicated to causes associated with advancing education and research.
“This is truly an exciting time for the Fortitude Group, I am honored to work with a fellow Mercyhurst Alum and feel strongly that my experience will compliment the exceptional efforts of our CEO Thomas Parilla- I have tremendous respect for Tom and consider him to be a man of the highest integrity.” “I believe our C-Suite team shares important values, we are passionate about innovation, and strive to be models of the principles and practices we deliver to our internal and external customers with integrity, respect, and responsibility. Our team has a genuine focus upon our core foundational belief: sustained superior performance.” Cuzzola stated.
Thomas Parilla, CEO of Fortitude Group Inc., commented “Chris is a very accomplished executive who possess enormous talent and passion for our mission and a highly successful track record; furthermore, his unique ability to connect the science of innovation to marketing and sales strategy in the highly competitive life science industry ensures a bright future for our Life Science Division.” “This is a challenging time in healthcare and with these challenges we see unique opportunities, our vision is to save patient lives.” Chris will build an exceptional team with tremendous clinical experience, meeting the healthcare providers needs in this dynamic market.”
